Excretion of Hypoxanthine and Xanthine in a Genetic Disease of Purine Metabolism
- 1 August 1967
- journal article
- Published by Springer Nature in Nature
- Vol. 215 (5103) , 859-860
- https://doi.org/10.1038/215859a0
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Genetics of an X-Linked Disorder of Uric Acid Metabolism and Cerebral FunctionPediatric Research, 1967
- Session III: Secondary Hyperuricaemia: Allopurinol in the Prevention of Hyperuricaemia Secondary to the Treatmient of Neoplastic Diseases with Alkylating Agents, Adrenal Steroids, and Radiation TherapyAnnals of the Rheumatic Diseases, 1966
- Session I: Biochemistry and Metabolism: Effects of Alloplurnol in Relation to Purine BiosynthesisAnnals of the Rheumatic Diseases, 1966
- Effect of allopurinol (4-Hydroxypyrazolo-(3,4-d)pyrimidine) on serum and urinary uric acid in primary and secondary goutThe American Journal of Medicine, 1964
- A familial disorder of uric acid metabolism and central nervous system functionThe American Journal of Medicine, 1964
- Xanthinuria and HemochromatosisNew England Journal of Medicine, 1964
- Augmentation of the incorporation of hypoxanthine into nucleic acids by the administration of an inhibitor of xanthine oxidaseBiochimica et Biophysica Acta (BBA) - Specialized Section on Nucleic Acids and Related Subjects, 1963
- ON THE MECHANISM OF OVERPRODUCTION OF URIC ACID IN PATIENTS WITH PRIMARY GOUT1Journal of Clinical Investigation, 1958
- Enzymic Determination of Hypoxanthine and Xanthine in Human Plasma and Urine.Acta Pharmacologica et Toxicologica, 1955